These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 35241534)

  • 41. Adverse drug reactions reporting in Calabria (Southern Italy) in the four-year period 2011-2014: impact of a regional pharmacovigilance project in light of the new European Legislation.
    Leporini C; Marrazzo G; Mumoli L; Esposito S; Gallelli L; Mangano G; Brancati G; De Francesco EA; Russo E; De Sarro G;
    Expert Opin Drug Saf; 2017 May; 16(5):515-522. PubMed ID: 28395523
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interpreting adverse drug reaction (ADR) reports as hospital patient safety incidents.
    Davies EC; Green CF; Mottram DR; Pirmohamed M
    Br J Clin Pharmacol; 2010 Jul; 70(1):102-8. PubMed ID: 20642552
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Paediatric adverse drug reactions following use of asthma medications in Europe from 2007 to 2011.
    Aagaard L; Hansen EH
    Int J Clin Pharm; 2014 Dec; 36(6):1222-9. PubMed ID: 25288145
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacovigilance of herbal medicines: Concerns and future prospects.
    Choudhury A; Singh PA; Bajwa N; Dash S; Bisht P
    J Ethnopharmacol; 2023 Jun; 309():116383. PubMed ID: 36918049
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Exploring healthcare professionals' knowledge, attitude, and practices towards pharmacovigilance: a cross-sectional survey.
    Hussain R; Hassali MA; Hashmi F; Akram T
    J Pharm Policy Pract; 2021 Jan; 14(1):5. PubMed ID: 33397478
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Knowledge, Practice and Attitudes Toward Pharmacovigilance and Adverse Drug Reactions Reporting Process Among Health Care Providers in Dammam, Saudi Arabia.
    Ali MD; Hassan YA; Ahmad A; Alaqel O; Al-Harbi H; Al-Suhaimi NM
    Curr Drug Saf; 2018; 13(1):21-25. PubMed ID: 29256354
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of online reporting systems and their compatibility check with respective adverse drug reaction reporting forms.
    Maharshi V; Nagar P
    Indian J Pharmacol; 2017; 49(5):374-382. PubMed ID: 29515278
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of information letters on the reporting rate of adverse drug reactions and the quality of the reports: a randomized controlled study.
    Johansson ML; Hägg S; Wallerstedt SM
    BMC Clin Pharmacol; 2011 Sep; 11():14. PubMed ID: 21899766
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Does spontaneous adverse drug reactions' reporting differ between different reporters? A study in Toulouse Pharmacovigilance Centre.
    Nicol C; Moulis F; Bondon-Guitton E; Durrieu G; Montastruc JL; Bagheri H
    Therapie; 2019 Oct; 74(5):521-525. PubMed ID: 31029402
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Primary Care Medication Safety Surveillance with Integrated Primary and Secondary Care Electronic Health Records: A Cross-Sectional Study.
    Akbarov A; Kontopantelis E; Sperrin M; Stocks SJ; Williams R; Rodgers S; Avery A; Buchan I; Ashcroft DM
    Drug Saf; 2015 Jul; 38(7):671-82. PubMed ID: 26100143
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacovigilance in China: development and challenges.
    Zhao Y; Wang T; Li G; Sun S
    Int J Clin Pharm; 2018 Aug; 40(4):823-831. PubMed ID: 30051225
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Estimation of adverse drug reaction reporting in Iran: Correction for underreporting.
    Khalili M; Mesgarpour B; Sharifi H; Golozar A; Haghdoost AA
    Pharmacoepidemiol Drug Saf; 2021 Aug; 30(8):1101-1114. PubMed ID: 33772938
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systematic review of paediatric studies of adverse drug reactions from pharmacovigilance databases.
    Cliff-Eribo KO; Sammons H; Choonara I
    Expert Opin Drug Saf; 2016 Oct; 15(10):1321-8. PubMed ID: 27501085
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reporting, handling, and subjective importance of adverse drug reactions among general practitioners: an exploratory cross-sectional survey.
    Gahr M; Connemann B; Zeiss R; Schönfeldt-Lecuona C; Dreyhaupt J; Lazik C
    Expert Opin Drug Saf; 2021 Aug; 20(8):979-985. PubMed ID: 34014779
    [No Abstract]   [Full Text] [Related]  

  • 55. Safety of medicines-Pharmacists' knowledge, practice, and attitudes toward pharmacovigilance and adverse drug reactions reporting process.
    Kopciuch D; Zaprutko T; Paczkowska A; Ratajczak P; Zielińska-Tomczak Ł; Kus K; Nowakowska E
    Pharmacoepidemiol Drug Saf; 2019 Dec; 28(12):1543-1551. PubMed ID: 31148344
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adverse drug reaction management in hospital settings: review on practice variations, quality indicators and education focus.
    Aung AK; Walker S; Khu YL; Tang MJ; Lee JI; Graudins LV
    Eur J Clin Pharmacol; 2022 May; 78(5):781-791. PubMed ID: 35171316
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Drug-related deaths: an analysis of the Italian spontaneous reporting database.
    Leone R; Sottosanti L; Luisa Iorio M; Santuccio C; Conforti A; Sabatini V; Moretti U; Venegoni M
    Drug Saf; 2008; 31(8):703-13. PubMed ID: 18636789
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adverse drug reactions in the paediatric population in Denmark: a retrospective analysis of reports made to the Danish Medicines Agency from 1998 to 2007.
    Aagaard L; Weber CB; Hansen EH
    Drug Saf; 2010 Apr; 33(4):327-39. PubMed ID: 20297864
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Public confidence in ADR identification and their views on ADRreporting: mixed methods study.
    Jarernsiripornkul N; Patsuree A; Krska J
    Eur J Clin Pharmacol; 2017 Feb; 73(2):223-231. PubMed ID: 27837337
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An investigation of pharmacovigilance and reporting of adverse drug reactions in hospitals: a cross-sectional study in China.
    Zhao Z; Shen J; Shen C; Zhu B; Sun J; Yu J; Sun F; Song H
    Curr Med Res Opin; 2021 Nov; 37(11):2001-2006. PubMed ID: 34376068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.